Circular and Notice of General Meeting

Medpal AI PLC

09 October 2026

 

9 October 2026

MedPal AI plc

(“MedPal”, the “Company” or the “Group”)

Circular and Notice of General Meeting

Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that a shareholder circular convening a General Meeting has been posted on the Company’s website at:

www.medpalplc.com/agm-and-gm-notices

The circular, together with a form of proxy, will shortly be sent to registered shareholders. The General Meeting has been convened for 10:00 a.m. on 29 October 2026 at the offices of Wedlake Bell LLP, 71 Queen Victoria Street, London, EC4V 4AY.

Proxy voting will be available from 5:00 p.m. today and instructions can be found in the circular.

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

	Time / Date 2026
Electronic publication of the circular by	10:00 a.m. on 9 October
Posting of Circular to Shareholders	9 October
Latest time and date for receipt of individual Forms of proxy / electronic proxy appointments	10:00 a.m. on  27 October
Record date for attendance at the General Meeting	6.00 p.m. on 27 October
General Meeting	10:00 a.m. on 29 October

Future times and dates are indicative only and are subject to change by the Company. If the expected timetable of events changes from the above, the Company will notify the Shareholders to this effect via Regulatory Information Service.

References to time in this announcement are to London times.

For further information please contact:

Enquiries:

MedPal AI plc Jason Drummond, Chief Executive Officer	Via Square1 Consulting
Cairn Financial Advisers LLP (Nomad) Louise O'Driscoll / Jo Turner	[phone]
Merlin Partners LLP (Broker)	[phone]
Clear Capital Markets Limited (Broker) Bob Roberts	[phone]
Square1 Consulting – (Financial PR) David Bick	[phone] / [phone]

About MedPal AI plc

MedPal AI plc (AIM: MPAL; FRA: Z1N) is a vertically integrated, AI-native digital health and pharmacy group. The Group operates NHS Distance Selling Pharmacy hubs at Sarus Court, Runcorn and Swaffham, New Health (new.co.uk), a dedicated GLP-1 weight management clinic, a B2B care home pharmacy supply business, eMARx, the Group’s electronic medication administration record software for care homes, and Juno, an agentic AI health companion built on Anthropic’s Claude. MedPal’s ambition is to build the UK’s leading Health OS: a single platform connecting prescribing, dispensing, delivery, administration and AI-driven patient support. The Company’s LEI is 984500EDP8B0A14CBA61.

END

 

END